Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-10-29, Stock:ABBV, The news for the past five days is as follows:
2021-10-22: NEWS1: AbbVie (ABBV) Earnings Expected to Grow: Should You Buy?.NEWS2: Pharma Stock Roundup: JNJ Mixed Q3 Results, FDA Nod to Mix & Match COVID Boosters.NEWS3: AbbVie and More Companies That Are Expected to Raise Their Dividends.
2021-10-25: NEWS1: Buy This Great High-Yield Dividend Stock?.NEWS2: AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know.NEWS3: Investors in AbbVie (NYSE:ABBV) have made a strong return of 138% over the past five years.NEWS4: What Could These Clinical Results Mean for AbbVie's Shareholders?.
2021-10-26: NEWS1: AbbVie (ABBV) to Report Q3 Earnings: What's in the Cards?.NEWS2: The 7 Best Stocks to Buy to Profit From the Rich.NEWS3: Allergan, an AbbVie Company, to Present New Data on Investigational AGN-190584 for the Treatment of Presbyopia.
2021-10-27: NEWS1: AbbVie Stock Is Making A Comeback On Inflammatory Drugs — Is It A Buy Now?.NEWS2: Recovery in Drugs Sales to Aid AbbVie's (ABBV) Q3 Earnings.NEWS3: Healthcare ETFs in Focus as Q3 Earnings Unfold.NEWS4: AbbVie Takes Another Step Toward Its Post-Humira Future.NEWS5: 3 Stocks You Can Still Buy on Sale in a Ridiculously Expensive Market.
2021-10-28: NEWS1: What Investors Should Pay Attention to in AbbVie's Q3 Earnings Report.NEWS2: Should Investors Worry About AbbVie?.NEWS3: AbbVie Announces ABBV-951 (Foslevodopa/Foscarbidopa) Showed Improvement in Controlling Motor Fluctuations Compared to Oral Levodopa/Carbidopa Medication in Pivotal Phase 3 Trial in Patients with Advanced Parkinson's Disease.

Answer: Rise